World News
Politics
Stock
Investing
Editor’s Pick

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025

June 4, 2025

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

previous post

The Best Five Sectors, #21

next post

Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

Related Posts

Biggest Canadian Defense Contractors and ETFs in 2025

July 17, 2025

Silver Price Update: Q2 2025 in Review

July 17, 2025

Apple, MP Materials Ink US$500 Million Deal to...

July 17, 2025

Barrick Mulls Canadian Exit as Mali Gold Tensions...

July 17, 2025

5 Best-performing Gold Stocks on the TSX in...

July 17, 2025

Biggest US Defense Contractors and ETFs in 2025

July 16, 2025

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name
Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

Inflation picks up again in June as tariffs slowly work their way through U.S. economy

July 17, 2025
Tech Takes the Spotlight Again—Are You Watching These Stocks?

July 17, 2025
This Tool Could Change Your Options Trading Forever

July 17, 2025
Four Symbols, One Big Message: What the Charts are Telling Us

July 17, 2025
30 Dow Stocks in 20 Minutes: Joe Rabil’s Mid-Year Technical Check

July 17, 2025

About us
Contact us
Privacy Policy
Terms & Conditions

Copyright © 2025 timeandsalesreporter.com | All Rights Reserved

World News
Politics
Stock
Investing
Editor’s Pick

Read alsox

What Can the Feds Legally Demand of Columbia...

March 17, 2025

AI Isolationism’s Risks: The Unintended Consequences of Banning...

March 20, 2025

Keep Politics Out of GDP Calculations

March 5, 2025